Introduction {#s1}
============

Infections are responsible for a substantial portion of community acquired acute kidney injury (AKI) in India. The commonly implicated conditions include malaria, leptospirosis, dengue, enteric fever, viral and bacterial infections. Despite being endemic in Asia with an estimated one million cases occurring annually, scrub typhus, caused by the rickettsia *Orientia tsutsugamushi*, is highly underdiagnosed and under-reported cause of hospitalization [@pntd.0002605-WHO1], [@pntd.0002605-Watt1]. World Health Organization (WHO) identifies scrub typhus as a re-emerging disease in South-East Asia and the South-Western Pacific region with a case fatality rate of up to 30% in untreated cases and stresses the need for its surveillance [@pntd.0002605-WHO1]. Scrub typhus has been reported from various parts of India [@pntd.0002605-Sharma1]--[@pntd.0002605-Vikrant1], and has recently been identified as one of the important neglected zoonoses of public health importance [@pntd.0002605-John1].

Scrub typhus is considered as an uncommon cause of AKI even in endemic areas. Renal involvement is thought to be a consequence of multi-organ dysfunction syndrome secondary to sepsis [@pntd.0002605-Raoult1], [@pntd.0002605-Reller1]. In part, this has been due to inability to make an accurate diagnosis due to non-availability of investigations. Recent studies have suggested a higher prevalence of kidney involvement in this condition. These studies, however, have used either clinical features alone or in combination with serology with single sample arbitrary antibody titre cut offs [@pntd.0002605-Chogle1] to make a diagnosis. Reliability on serology alone is problematic in endemic areas, and use of nucleic acid based testing (NAT) is recommended [@pntd.0002605-Saisongkorh1]--[@pntd.0002605-Richards1].

We prospectively studied the pattern of kidney involvement and its impact on the outcome in scrub typhus patients who were diagnosed by using a strict NAT based case definition.

Materials and Methods {#s2}
=====================

Ethics statement {#s2a}
----------------

The study was approved by the Institute Ethics Committee of the Postgraduate Institute of Medical Education and Research. Written informed consent was obtained from all adult patients and from the parents or legal guardians of minor subjects. The study was conducted in accordance to the principles of the Declaration of Helsinki.

Study setting and subjects {#s2b}
--------------------------

This study was done at the Nehru Hospital of Postgraduate Institute of Medical Education and Research, the largest tertiary care referral hospital in North India located near the foothills of The Great Himalayas. From September 2011 to November 2012, all patients referred to our hospital with unexplained fever and/or varying degrees of multisystem involvement were tested for *O. tsutsugamushi* deoxyribonucleic acid (DNA) in blood by nested polymerase chain reaction (PCR) targeting gene encoding for the 56-kDa antigen of Gilliam strain of *O. tsutsugamushi* [@pntd.0002605-Furuya1].

All patients also underwent at least three blood cultures for bacterial growth, three peripheral blood film examinations for malarial parasite and malarial antigen detection in blood by immunochromatographic rapid card test (QDx Malaria PAN/Pf and Pv/Pf, Piramal Healthcare, India). In addition, dengue virus NS1 antigen, dengue virus IgM antibody and leptospiral IgM antibody were tested in blood samples of all patients.

Demographic details and clinical course were recorded for all patients. A detailed history which included recording of signs and symptoms, occupational details, geographic and social background, previous co-morbidities and treatment was taken and complete physical examination was done in all patients to specifically look for presence of eschar, rash and lymphadenopathy. All routine hematological and biochemistry profiles were noted at admission and follow up. Urine was tested using dipstick for albumin and sugar, and microscopic examination of freshly voided urine specimen was performed in all patients. Hourly urine output and daily serum creatinine monitoring were done during hospital stay. Complications were noted for all patients.

Variables {#s2c}
---------

A confirmed case of scrub typhus was defined as the one with positive nested PCR for *O. tsutsugamushi* with no other evidence of any other infection. As single point qualitative immunoglobulin M (IgM) enzyme linked immunosorbent assay (ELISA) has been extensively used to define cases of scrub typhus in published literature especially from our region where the disease appears to be highly endemic, scrub typhus IgM antibody was also looked for in patients\' sera by ELISA in all cases by commercially available qualitative ELISA kit (InBios International, Inc., USA) according to the manufacturer\'s instructions. The test was considered to be positive if the antibody was present at dilution of ≥1∶100 as defined by the manufacturer.

Shock was defined as systolic blood pressure \<90 mm Hg or requirement of inotropes; acute respiratory distress syndrome (ARDS) defined as PaO2/FiO2≤300 mm Hg [@pntd.0002605-Ranieri1]; severe anemia as hemoglobin \<9 g/dL; leukocytosis as total leukocyte count \>11000 cells/µL; leukopenia as total leukocyte count \<4000 cells/µL; thrombocytopenia as platelet count \<100000 cells/µL; hypoalbuminemia as serum albumin \<3.5 g/dL; hyperbilirubinemia as serum total bilirubin \>1.2 mg/dL; elevated serum glutamate oxaloacetate aminotransferase (SGOT) as \>40 U/L; elevated serum glutamate pyruvate aminotransferase (SGPT) as \>40 U/L and elevated serum alkaline phosphatase (SAP) as \>130 U/L.

AKI was defined and staged according to Kidney Disease: Improving Global Outcomes (KDIGO) definition [@pntd.0002605-Kidney1].

Polymerase chain reaction for 56-kDa antigen of of *O. tsutsugamushi* {#s2d}
---------------------------------------------------------------------

Genomic DNA was isolated from buffy coat of 5 ml blood collected in ethylenediaminetetraacetic acid (EDTA) vial using QIA amp DNA mini kit according to manufacturer\'s instructions (Qiagen. Hilden, Germany). Nucleotide specific sequence amplification was done for the presence of 56-kDa antigen of of *O. tsutsugamushi*. A set of nested PCR primers were used for two rounds of amplification (outer primers, forward: TCAAGCTTATTGCTAGTGCAATGTCTGC, reverse: AGGGATCCCTGCTGCTGTGCTTGCTGCG; inner primers, forward: GATCAAGCTTCCTCAGCCTACTATAATGCC, reverse: CTAGGGATCCCGACAGATGCACTATTAGGC) using conditions described earlier [@pntd.0002605-Furuya1], [@pntd.0002605-Kwok1]. Visualization of specific 483 bp amplification product was considered to be diagnostic ([Figure 1](#pntd-0002605-g001){ref-type="fig"}). A previously confirmed scrub typhus patient sample (fever with eschar, ≥4 fold rise in IgM antibody titres by enzyme linked immunosorbent assay and positive nested PCR for gene encoding 56-kDa antigen of *O. tsutsugamushi* confirmed by sequencing) was taken as positive control. For each run, one positive human control, one healthy negative human control and one negative control (without any DNA) were run simultaneously to confirm the accuracy. Sequencing of PCR product was done in 3 randomly selected patients. Sequence alignment was done with nucleotide blast on pubmed and analyzed using Molecular Evolutionary Genetics Analysis (MEGA) software for phylogenetic tree analysis. The results showed \>98% homology with *O. tsutsugamushi* family strains ([Figure 2](#pntd-0002605-g002){ref-type="fig"}, test sequence highlighted). This nested PCR was also performed on eschar tissue scraped from 2 patients who had positive blood samples.

![The ethidium bromide-stained agarose gel shows the 483 bp polymerase chain reaction products.\
L: 500 bp ladder, 1--4: patients\' samples; 5: positive control; 6: negative control.](pntd.0002605.g001){#pntd-0002605-g001}

![Phylogenetic tree analysis, highlighted test sample shows \>98% homology to *O. tsutsugamushi*.](pntd.0002605.g002){#pntd-0002605-g002}

Management {#s2e}
----------

The patients were treated with either doxycycline (100 mg twice daily for 7 days) or azithromycin (500 mg daily for 3 days). Fluid overload, hyperkalemia or metabolic acidosis refractory to medical measures, or persistent oliguria were indications for starting dialysis.

Outcomes {#s2f}
--------

Urinalysis abnormalities and AKI were the outcomes of interest. The study population was divided into two groups based on presence or absence of AKI.

Statistical analysis {#s2g}
--------------------

Data was analysed using Statistical Package for the Social Sciences (SPSS) software for Windows, version 20.0 (IBM Corp., Armonk NY). Univariate analysis was done to assess association of various parameters with presence of AKI and final outcome. Binary logistic regression analysis (forward conditional) was used to look for independent association of clinical and laboratory factors with the outcome. All p values were two-tailed, and considered to be significant at \<0.05.

Results {#s3}
=======

Out of 201 patients with fever and multisystem involvement seen during this period, 49 tested positive for *O. tsutsugamushi* DNA. None of these had any alternative diagnosis ([Table 1](#pntd-0002605-t001){ref-type="table"}). Amongst 152 patients who were negative for scrub typhus by aforementioned PCR, 20% patients had an alternative diagnosis ([Table 2](#pntd-0002605-t002){ref-type="table"}). Importantly, a total of 105 patients were recorded as positive for scrub typhus IgM ELISA. These included 43% of scrub typhus PCR negative patients. A total of 23% of patients within this subset (scrub typhus PCR negative but IgM ELISA positive) were assigned an alternative diagnosis. A comparison of the clinical features and laboratory abnormalities in scrub typhus positive and negative patients is given in [Table 1](#pntd-0002605-t001){ref-type="table"}. Vomiting, altered sensorium, bodyaches, tachycardia, hepatomegaly, lymphadenopathy, AKI and thrombocytopenia were significantly more common in patients with scrub typhus ([Table 1](#pntd-0002605-t001){ref-type="table"}).

10.1371/journal.pntd.0002605.t001

###### Clinical and laboratory manifestations in patients (total no. of patients: 201).

![](pntd.0002605.t001){#pntd-0002605-t001-1}

  Parameter                            Scrub typhus (n = 49)   Others (n = 152)     P value
  ----------------------------------- ----------------------- ------------------ -------------
  **Symptoms**                                                                   
  Fever                                         48                   151             0.396
  Shortness of breath                           33                    80             0.071
  Jaundice                                      21                    50             0.205
  Pain abdomen                                  15                    47             0.968
  Vomiting                                      15                    18           **0.002**
  Decreased urine output                        13                    36             0.687
  Headache                                      14                    37             0.554
  Altered sensorium                             12                    16           **0.014**
  Bleeding manifestations                       10                    16             0.073
  Loose motions                                  5                    12             0.613
  Bodyaches                                      3                    1            **0.017**
  Seizures                                       2                    16             0.169
  **Signs**                                                                      
  Tachycardia                                   36                    54          **\<0.001**
  Hepatomegaly                                  34                    77           **0.022**
  Tachypnea                                     33                    87             0.210
  Splenomegaly                                  20                    49             0.271
  Lymphadenopathy                               10                    7            **0.002**
  Eschar                                         9                    2           **\<0.001**
  Rash                                           2                    20             0.077
  **Complications**                                                              
  Shock                                          8                    12             0.086
  ARDS                                          28                    75             0.342
  AKI                                           26                    52           **0.020**
  Mortality                                      8                    4           **\<0.001**
  **Investigations**                                                             
  Hemoglobin (g/dL)                          10.3±2.5              9.9±2.5           0.381
  TLC (per µL)                              11667±6539            11702±8813         0.980
  Platelet count (per µL)                  84,804±71,786       129,504±117,721     **0.016**
  Serum total bilirubin (mg/dL)               4.9±7.9              3.6±6.0           0.251
  SGOT (U/L)                                 378±1299              190±317           0.149
  SGPT (U/L)                                  160±408              133±189           0.577
  SAP (U/L)                                   279±258              308±334           0.623
  Total protein (g/dL)                        6.2±1.1              6.1±0.9           0.577
  Serum albumin (g/dL)                        3.0±0.7              3.0±0.7           0.886
  Serum creatinine (mg/dL)                    1.9±1.5              1.9±2.3           0.910
  Scrub typhus IgM ELISA positivity             39                    66          **\<0.001**

AKI: acute kidney injury, ARDS: acute respiratory distress syndrome, ELISA: enzyme linked immunosorbent assay, IgM: immunoglobulin M, PCR: polymerase chain reaction, SAP: serum alkaline phosphatase SGOT: serum glutamate oxaloacetate aminotransferase, SGPT: serum glutamate pyruvate aminotransferase, TLC: total leukocyte count.

10.1371/journal.pntd.0002605.t002

###### Diagnoses in scrub typhus PCR negative population.

![](pntd.0002605.t002){#pntd-0002605-t002-2}

                                 Scrub typhus IgM ELISA                                             
  ----------------------- ------------------------------------ ------------------------------------ -----
  No of cases                              66                                   86                   152
  Unknown                                  51                                   70                   121
  Malaria                                  5                                    5                    10
  Dengue                                   4                                    3                     7
  Pyogenic meningitis                      2                                    0                     2
  Hepatitis A                              1                                    1                     2
  Hepatitis E                              1                                    0                     1
  Japanese encephalitis                    1                                    0                     1
  Leptospirosis                            0                                    1                     1
  Tuberculosis                             0                                    1                     1
  Others                   1[\*](#nt102){ref-type="table-fn"}   5[\#](#nt103){ref-type="table-fn"}    6

Drug Reaction with Eosinophila and Systemic Symptoms (DRESS);

^\#^ Still\'s disease, erythema nodosum, polymyositis, dapsone syndrome, thrombotic microangiopathy.

ELISA: enzyme linked immunosorbent assay, IgM: immunoglobulin M, PCR: polymerase chain reaction.

Males constituted 59% of the scrub typhus PCR positive cases. The mean age was 34.1±14.4 (range 11--65) years and the duration of symptoms at presentation was 10.8±4.9 (range 3--30) days. About 84% patients were from rural areas. No cases were diagnosed during summer months from March to June. Majority of the cases occurred after rainy season in July--August and continued through winter.

[Table 3](#pntd-0002605-t003){ref-type="table"} lists the clinical manifestations recorded in this study population. In addition to fever, the main symptoms were shortness of breath, jaundice, pain abdomen, vomiting, decreased urine output, headache and altered mentation. Tachycardia, hepatomegaly, tachypnea and splenomegaly were noted in 73%, 69%, 67% and 41% of the patients, respectively. Eschar was noted in 9 cases; the location being chest (3) and nape of neck, arm, index finger of hand, hypogastric region, gluteal region and popliteal fossa. Amongst these confirmed cases, IgM ELISA for scrub typhus was positive in 80%.

10.1371/journal.pntd.0002605.t003

###### Comparison of clinical, laboratory manifestations and complications in the AKI and non-AKI groups in the confirmed scrub typhus study population (scrub typhus PCR positive, no. of patients: 49).
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  Parameter                            AKI (n = 26)   No AKI (n = 23)   P value (two tailed)
  ----------------------------------- -------------- ----------------- ----------------------
  **Symptoms**                                                         
  Fever                                     26              22                 0.283
  Shortness of breath                       20              13                 0.129
  Jaundice                                  16               5               **0.005**
  Pain abdomen                              6                9                 0.224
  Vomiting                                  7                8                 0.551
  Oliguria                                  13               0              **\<0.001**
  Headache                                  7                7                 0.786
  Altered sensorium                         8                4                 0.277
  Bleeding manifestations                   5                5                 0.828
  Loose motions                             2                3                 0.537
  Bodyaches                                 3                0                 0.093
  Seizures                                  1                1                 0.929
  **Signs**                                                            
  Tachycardia                               20              16                 0.560
  Hepatomegaly                              18              16                 0.980
  Tachypnea                                 18              15                 0.765
  Splenomegaly                              13               7                 0.164
  Lymphadenopathy                           4                6                 0.354
  Eschar                                    5                4                 0.868
  Rash                                      1                1                 0.929
  **Others**                                                           
  Shock                                     6                2                 0.174
  ARDS                                      17              11                 0.215
  Mortality                                 8                0               **0.004**
  **Investigations**                                                   
  Hemoglobin (g/dL)                      10.7±2.8         9.7±2.2              0.174
  TLC (per µL)                          11923±6750      11363±6426             0.771
  Platelet count (per µL)              82560±75525      87476±68821            0.820
  Serum total bilirubin (mg/dL)          7.6±9.7          1.8±2.9            **0.013**
  SGOT (U/L)                             587±1742         124±96               0.255
  SGPT (U/L)                             226±538           75±45               0.243
  SAP (U/L)                              336±318          217±158              0.152
  Total protein (g/dL)                   6.2±1.2          6.2±1.0              0.848
  Serum albumin (g/dL)                   2.8±0.6          3.1±0.8              0.387
  Blood urea (mg/dL)                      137±68           44±29            **\<0.000**
  Serum creatinine (mg/dL)               2.8±1.5          0.8±0.2           **\<0.000**
  Scrub typhus IgM ELISA positivity         25              14               **0.002**
  **Complication**                                                     
  Severe anemia                             8                7                 0.980
  Leukocytosis                              10               8                 0.881
  Leukopenia                                0                1                 0.272
  Thrombocytopenia                          17              15                 0.801
  Hypoalbuminemia                           18              15                 0.817
  Hyperbilirubinemia                        19               7               **0.002**
  Elevated SGOT                             20              15                 0.488
  Elevated SGPT                             18              11                 0.231
  Elevated SAP                              14              11                 0.431

AKI: acute kidney injury, ARDS: acute respiratory distress syndrome, ELISA: enzyme linked immunosorbent assay, IgM: immunoglobulin M, PCR: polymerase chain reaction, SAP: serum alkaline phosphatase SGOT: serum glutamate oxaloacetate aminotransferase, SGPT: serum glutamate pyruvate aminotransferase, TLC: total leukocyte count.

Renal abnormalities were noted in 82% of the scrub typhus patients ([Table 4](#pntd-0002605-t004){ref-type="table"}). Abnormal urinalysis was present in 61%, the major abnormalities being dipstick positive albuminuria (55%) and microscopic hematuria (16%). AKI, as defined according to KDIGO definition, was seen in 53% of patients. A total of 5 (10%) patients were in stage 1, 4 (8%) in stage 2 and 17 (35%) in stage 3. Jaundice, oliguria and mortality were significantly more in patients with AKI ([Table 3](#pntd-0002605-t003){ref-type="table"}). About half of all patients with AKI were oliguric. There were no significant differences between the oliguric and non-oliguric scrub typhus patients with AKI except for mortality which was significantly higher in oliguric patients (p = 0.011). Gross, painless hematuria was seen in two patients, and one had intravascular hemolysis. A 14-year-old male who presented with fever and gross hematuria underwent a kidney biopsy that showed mesangial hypercellularity with 2+ mesangial deposition of immunoglobulin A (IgA). He continued to have microscopic hematuria after 6 months. One patient had nephrotic range proteinuria at presentation that rapidly improved over 2 weeks and hence, biopsy was not done. Three patients required dialysis.

10.1371/journal.pntd.0002605.t004

###### Renal abnormalities in the confirmed scrub typhus study population (no. of patients: 49).

![](pntd.0002605.t004){#pntd-0002605-t004-4}

  Parameter                                                               No. of patients (%)
  ---------------------------------------------------------------------- ---------------------
  Oliguria (\<400 ml/d)                                                         13 (26)
  Gross hematuria                                                                2 (4)
  Dysuria                                                                        1 (2)
  Hemoglobinuria                                                                 1 (2)
  Abnormal urinalysis                                                           30 (61)
  Dipstick positive albuminuria                                                 27 (55)
  • ≤2+                                                                         26 (53)
  • \>2+                                                                         1 (2)
  Dipstick positive glucosuria                                                   1 (2)
  Significant pyuria (\>9 pus cells/hpf)                                         3 (6)
  Microscopic hematuria (\>2 RBC/hpf)[\#](#nt106){ref-type="table-fn"}          8 (16)
  AKI[\$](#nt107){ref-type="table-fn"}                                          26 (53)
  Stage 1                                                                       5 (10)
  Stage 2                                                                        4 (8)
  Stage 3                                                                       17 (35)

^\#^ excludes two patients with gross hematuria;

defined according to KDIGO guidelines for AKI.

AKI: acute kidney injury, KDIGO: Kidney Disease: Improving Global Outcomes, RBC: red blood cell.

Prominent hematological abnormalities included thrombocytopenia, leucocytosis and severe anemia ([Table 3](#pntd-0002605-t003){ref-type="table"}). Hyperbilirubinemia, transaminitis, and hypoalbuminemia were also seen in majority of patients. Over 50% patients developed ARDS. Secondary hemophagocytosis and septic arthritis were seen in one patient each. Interestingly, two of the patients were kidney transplant recipients.

Patients with characteristic eschar were immediately started on treatment once blood samples were collected for testing. Otherwise, specific treatment for scrub typhus was started only after diagnosis was confirmed. The disease was fatal in 8 patients, all of whom had ARDS and AKI. All three patients who required dialysis expired. On univariate analysis, jaundice, oliguria, elevated bilirubin, elevated SGOT, elevated SGPT, ARDS and AKI were significantly associated with mortality (p of 0.045, \<0.0001, 0.005, 0.022, 0.039, 0.007 and 0.004, respectively). There was no significant association of stage of AKI with mortality (p = 0.214). On multivariate analysis, only oliguric AKI showed an independent association with mortality (p = 0.002, Cox & Snell R Square 0.309).

Except the person with persistent hematuria, all surviving patients had normal renal function and normal urinalysis at 3 months after recovery.

Discussion {#s4}
==========

This is the first report to comprehensively document the clinical picture, investigative profile, pattern of renal involvement and outcome in a cohort of patients of scrub typhus using a strict case definition. We show that scrub typhus is responsible for about 24% of all patients presenting with unexplained febrile illness and/or multi-system involvement. We also show that the renal involvement is fairly common in scrub typhus. AKI is seen in over 50% cases, and is an important predictor of mortality.

Scrub typhus is caused by obligate, intracellular bacterium *O. tsutsugamushi* which is maintained in nature by trans-ovarian transmission in trombiculid mites. Human involvement occurs accidentally when they get bitten by infected trombiculid mite larvae (chiggers) leading to inoculation of organisms into skin. Vascular endothelial cell injury leading to vasculitis is the predominant mechanism of cellular injury in this disease.

Scrub typhus does not find a mention in most descriptions of tropical community acquired AKI. In part, the reason has been inability to make an accurate diagnosis. The clinical description lays emphasis on the presence of an eschar, which is often difficult to see in dark-skinned persons. Supporting tests include either demonstration of rising antibody titre or rickettsial DNA [@pntd.0002605-Richards1]. Serologic tests are plagued by under-reporting of methodology and variable seropositivity criteria. [@pntd.0002605-Richards1], [@pntd.0002605-Blacksell1]. Most Indian reports have relied on a single point commercially available IgM ELISA using cutoffs that have been derived from low endemicity areas. A major limiting factor is lack of availability of local seroprevalence dats. Single time point estimations should be used only when robust local seroprevalence data is available [@pntd.0002605-Kim1], [@pntd.0002605-Blacksell1]. Variable single point titres in India (≥1∶100, ≥16 units) and Thailand (≥1∶400) have been reported as positive [@pntd.0002605-Chrispal1], [@pntd.0002605-Vikrant1], [@pntd.0002605-Saisongkorh1]. However, using serology alone, Paris et al used an admission IgM titer of ≥1∶12,800 (based on local seroprevalence data and highest titres seen during acute infections) or a four-fold rise in IgM antibody by immunofluorescence antibody assay (IFA) to define a case of scrub typhus in Thailand [@pntd.0002605-Paris1]. Therefore, use of single sample titres for making a positive diagnosis using arbitrary cutoff without local validation is strongly discouraged [@pntd.0002605-Richards1], [@pntd.0002605-Koh1], [@pntd.0002605-Paris2]. Unfortunately, seroprevalence data in Indian population is not available. Our study shows that diagnosis of scrub typhus using single time qualitative IgM antibody estimation by the commercially available IgM ELISA kit would have failed to diagnose scrub typhus in 20% of PCR positive confirmed cases.

Nested PCR targeting gene encoding for the 56-kDa antigen of Gilliam strain of *O. tsutsugamushi* has been shown to have high sensitivity and specificity. This primer set has been shown to amplify DNA sequences from other strains of *O. tsutsugamushi* [@pntd.0002605-Saisongkorh1], [@pntd.0002605-Furuya1], [@pntd.0002605-Furuya2], [@pntd.0002605-Ohashi1], and has been suggested as a group specific test for *O. tsutsugamushi* [@pntd.0002605-Saisongkorh1]. Importantly, this PCR has been shown to be negative in normal humans and other infections. It is important to note that the serotype specific primers are different from this set and have been described in literature [@pntd.0002605-Furuya1]. In a study of 36 patients who presented with fever at a large provincial hospital in Southern Thailand, nested PCR for gene encoding the 56 kDa antigen of Gilliam strain of *O. tsutsugamushi* was compared with IFA (both acute and convalescent sera in only 17 patients) [@pntd.0002605-Saisongkorh1]. This PCR detected all 9 patients who were diagnosed by serology (positive if single point titre of \>1∶400 or a four-fold rise in titre to at least 1∶200), and in addition was positive in 3 more patients who were negative by serology. The reported range for days after onset of disease and specific drug treatment when samples were taken for testing ranged from 5--33 days and 1--27 days, respectively. Importantly, this PCR was negative in healthy human controls and murine typhus patients. Also, the investigators showed that this PCR amplified DNA of 9 other strains of *O. tsutsugamushi* prevalent in South-East Asia and suggested that it could be used to detect diverse antigenic types of *O. tsutsugamushi*. In a study from Korea, nested PCR for gene encoding the 56 kDa antigen of *O. tsutsugamushi* was shown to have a sensitivity of 82.2% and a specificity of 100% when compared with IFA (diagnosis made by either single point titres cut off or four fold rise in titres in convalescent sera) [@pntd.0002605-Kim2]. In another recent study from the same centre where the investigators compared various types of PCR (47 kDa gene, 56 kDa gene) for scrub typhus diagnosis (confirmed only by four fold rise in convalescent sera titres by IFA), 56 kDa nested PCR was found to have the highest sensitivity (87.8%) and 100% specificity [@pntd.0002605-Kim1]. IFA which is considered current gold standard reference diagnostic method is imperfect, gives retrospective diagnosis and plagued by variability in methodology and arbitrarily defined cut off titres without supporting epidemiological data [@pntd.0002605-Paris2]. Theoretically, PCR based assays would offer diagnosis till bacteremia persists, before antibody response occurs in early phase of disease and overcome the problem of high background titres in endemic areas before antibody response starts appearing. However, once bacteremia has cleared with or without treatment, PCR based assays would be negative. Therefore, it has been suggested that future diagnostic development should preferably focus on both pathogen and antibody based tests [@pntd.0002605-Paris2]. Recently, a set of robust set of reference criteria comprising culture, serological cut offs backed by local epidemiological data and combination of various available PCRs has been proposed for validation of new diagnostic techniques for scrub typhus [@pntd.0002605-Paris1].

Therefore, our study appropriately highlights the current limitations of using such serologic tests for diagnosis of scrub typhus and suggests the need to obtain robust population data to determine appropriate cutoffs for diagnosis. Antibody titre estimation in paired serum samples may overcome these limitations, but the diagnosis would be retrospective in such a situation and may not help in immediately guiding treatment.

Using this nested PCR as confirmatory diagnostic criterion, 24% of patients with unexplained febrile illness seen at our centre had scrub typhus. In a study from South India [@pntd.0002605-Basu1], about 51% of all patients with febrile illness were diagnosed as scrub typhus on the basis of ELISA. It is important to note that there is no data from Indian population which validates antibody titre cutoffs put forward by manufacturer\'s in Western countries. Had we also based the diagnosis on serology, the prevalence would have been 57%. We did not note any geographic clustering. The condition was also seen in urban residents,who are traditionally considered to be at low risk [@pntd.0002605-Li1], [@pntd.0002605-Wang1]. Whether this is related to environment, host, pathogen or vector related factors needs further studies. Epidemiological investigation of a recent outbreak of scrub typhus in North-East India suggested emergence of a new species of vector trombiculid mite, *Schoengastiella ligula* [@pntd.0002605-Tilak1]. The increased incidence after rainy season is expected as increased vegetation after rains support growth of larvae of trombiculid mite, reflecting tropical disease epidemiology. There is a trend towards more use of fluoroquinolone, cephalosporins, extended spectrum penicillins and newer antibiotics in the community [@pntd.0002605-Chandy1], [@pntd.0002605-Kotwani1]. We believe that increasing use of these antibiotics for treatment of febrile illnesses in the community during recent times may be contributing to unmasking of this disease as the causative organism is inherently resistant to them.

Till recently, renal involvement due to scrub typhus had not received much attention. A recent systematic review could only find a few case reports specifically describing acute renal failure due to scrub typhus [@pntd.0002605-Rajapakse1]. Overall, renal involvement is considered to be a part of multi-organ dysfunction syndrome in patients with severe disease [@pntd.0002605-Raoult1], [@pntd.0002605-Reller1]. In Taiwan, incidence of AKI in scrub typhus was reported to be 8.3% and 6.6% in two series [@pntd.0002605-Wu1], [@pntd.0002605-Tsay1]. Importantly, clinical course in 8 out of 9 patients who developed acute renal failure in one of these series was complicated by septic shock which might have precipitated AKI [@pntd.0002605-Wu1]. In India, two series from South India have shown the incidence of AKI to be 19% and 42% ([Table 5](#pntd-0002605-t005){ref-type="table"}) [@pntd.0002605-Chrispal1], [@pntd.0002605-Basu1], [@pntd.0002605-Attur1], [@pntd.0002605-Kumar1]. A recent series from North India reported AKI in 34% patients [@pntd.0002605-Vikrant1]. It is important to note that that the basis of diagnosis has been a single point measurement of antibody using an arbitrary cutoff, and therefore subject to the above mentioned limitations. Our study is the first to use a robust diagnostic parameter to identify definitive cases and evaluate renal involvement.

10.1371/journal.pntd.0002605.t005

###### Renal involvement in scrub typhus.
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  Study                                                            Diagnostic criteria                           Region                             No. of patients, age of patients                         Urinalysis abnormalities                                               AKI definition                                                                                                   AKI                                                       Any other form of renal involvement
  -------------------------------------------- ----------------------------------------------------------- ------------------ ----------------------------------------------------------------------------- -------------------------- -------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------- -------------------------------------
  Kumar M, 2012 [@pntd.0002605-Kumar1]                           Clinical and Weil Felix                      South India                                   35, age ≤12 years                                      Not reported                                                          AKIN                                                    20% of all patients (stages 1, 2 and 3 reported as 29%, 42% and 29% of all patients with AKI, respectively)      Oliguria: 43% of all patients
  Basu G, 2011 [@pntd.0002605-Basu1]                                      ELISA                               South India                                  188, age ≥18 years                                      Not reported                                                         RIFLE                                                    42.6% of all patients (risk, injury and failure in 48%, 26% and 26% of all patients with AKI, respectively)  
  Chrispal A, 2010 [@pntd.0002605-Chrispal1]                            IgM ELISA                             South India                                  189, age ≥16 years                                      Not reported                                              Serum creatinine \>1.4 mg/dL                                                                                   19.6% of all patients                                                Oliguria: 10.6% of all patients
  Attur RP, 2013 [@pntd.0002605-Attur1]                          Weil Felix or IgM ELISA                    South-West India                            259, median age 39 years                              56.7% of all patients                                                     RIFLE                                                    23.2% of all patients (risk, injury and failure in 38%, 22% and 40% of all patients with AKI, respectively)  
  Vikrant S, 2013 [@pntd.0002605-Vikrant1]                              IgM ELISA                             North India      515, only data about patients with AKI presented (mean age 41.4±15.9 years)         Not reported                                                         RIFLE                                                     35% of all patients (risk, injury and failure in 45%, 34% and 21% of all patients with AKI, respectively)   
  Wu KM, 2009 [@pntd.0002605-Wu1]                                      IFA or PCR                            Eastern Taiwan                                 136, age ≥2 years                                      Not reported         ≥0.5 mg/dL increase in serum creatinine over baseline or lowest value OR 24 hour urine volume \<400 ml                                              6.6% of all patients                                              
  Berman SJ, 1973 [@pntd.0002605-Berman1]       IFA or mouse inoculation[\*](#nt109){ref-type="table-fn"}    South Vietnam                                     87, adults                                      20% of all patients                                           Elevated blood urea nitrogen                                                                                           None                                                      

Used ≥4 fold rise in antibody titre in paired serum samples if diagnosed by IFA.

AKIN: Acute Kidney Injury Network, ELISA: Enzyme Linked Immunosorbent Assay, IgM: Immunoglobulin M.

Renal abnormalities were present in 82% cases, and \>50% patients had AKI. Abnormal urinalysis was seen in 61% of patients. In a study from Vietnam, abnormal urinalysis, almost exclusively proteinuria, was reported in 20% of patients with scrub typhus diagnosed by IFA or mouse inoculation methods [@pntd.0002605-Berman1]. Mild proteinuria or microscopic hematuria have been reported in scrub typhus patients with acute renal failure [@pntd.0002605-Yen1]. A recent study from India reported abnormal urinalysis in 57% patients [@pntd.0002605-Attur1]. Low-grade albuminuria, along with microscopic hematuria, pyuria and glucosuria suggest predominant tubulo-interstitial involvement. Clinical evidence of glomerular involvement was seen in 2 cases, one as nephrotic range proteinuria that improved spontaneously, and the other with glomerular hematuria who was shown to have IgA nephropathy on biopsy. It is likely that concurrent febrile illness due to scrub typhus precipitated episode of gross hematuria in the second patient.

Other descriptions of acute renal failure in scrub typhus are in the form of case reports [@pntd.0002605-Yen1]--[@pntd.0002605-Young1] and one autopsy study [@pntd.0002605-Allen1]. The mechanism of AKI in scrub typhus is mainly believed to be impaired renal perfusion due to volume depletion or increased vascular permeability [@pntd.0002605-Kim3]. Other potential mechanisms include direct tubular toxicity leading to acute tubular necrosis, interstitial nephritis, pigment nephropathy due to rhabdomyolysis and thrombotic microangiopathy secondary to disseminated intravascular coagulation. Renal biopsies have shown mild mesangial hyperplasia, acute tubular necrosis or tubulointerstitial nephritis [@pntd.0002605-Hsu1], [@pntd.0002605-Kim3], [@pntd.0002605-Chi1]. The autopsy series published 67 years back described renal histopathologic changes in 69 patients with scrub typhus [@pntd.0002605-Allen1]. Proximal tubular epithelial swelling and interstitial nephritis were universal. Focal or diffuse glomerulonephritis was seen in 30% of kidney specimens. Fibrin filled capillaries or swollen endothelial cells leading to glomerular ischemia was another prominent observation. Kidneys were the second most common site of vascular changes after testes. Evidently, these findings represented involvement in severest form which led to death of patients.

In our study, the outcome of AKI was largely favourable as all the surviving patients with AKI had completely recovered their renal function. All 3 patients who had dialysis dependent AKI expired. This may be a reflection of underlying severity of disease. The significant association of hyperbilirubinemia with AKI and association of increased mortality with oliguric form of AKI may also be a reflection of the same. Basu et al [@pntd.0002605-Basu1] also showed increasing mortality risk with increasing severity of AKI.

There are some limitations to this study. Our study population is unlikely to represent the true burden of this disease as only those patients who had severe disease or were unresponsive to treatment in community health facilities would have been referred to our tertiary care centre. Secondly, the diagnosis was based on a single nucleic acid test. Other nucleic acid-based tests such as 47-kDa-based and GroEL-based real-time PCR and loop-mediated isothermal PCR [@pntd.0002605-Blacksell1] have also been used. It is possible that a combination of these along with culture and properly validated local serological criteria would allow identification of more cases.

Despite these limitation, our current observations are significant as they identify scrub typhus as an important cause of unexplained acute febrile illness in this region and contradict the current notion that AKI is uncommon complication in this disease. Whether the higher incidence of AKI in hospitalized patients with scrub typhus in our region compared to that reported from other centres is actually related to some host factor, differences in microbial virulence or is an actual unmasking of a previously unrecognized complication is difficult to infer due to variability and paucity of existing literature. Standardization of diagnostic criteria and uniform definitions of various manifestations when applied across various centres may help in this regard.

In conclusion, scrub typhus is an important cause of febrile illness with multisystem involvement in tropical regions. Renal involvement is common and AKI is an independent predictor of mortality. We suggest that the panel of investigation in all these cases should include PCR for O *tsutsugamushi*. The discrepancy between NAT positivity and IgM ELISA positivity as defined by arbitrary cutoffs suggests the need to develop robust local seroprevalence data.
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